Evidence map›Paper›PMID 39227506›Full record

ArticleEuropean journal of pediatrics2024

Etiology and clinical course of severe and extreme thrombocytosis in children: a retrospective single-center study.

Kenji Kishimoto, Daiichiro Hasegawa, Yasuo Nakagishi, Hiroshi Kurosawa, Toshikatsu Tanaka, Tadashi Hatakeyama, Yoshihiro Oshima, Yoshiyuki Kosaka

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kenji KishimotoDepartment of Hematology & Oncology, Kobe Children's Hospital, Minatojima-Minamimachi 1-6-7, Chuo-Ku, Kobe, 650-0047, Japan. ken@yacht.ocn.ne.jp.
Daiichiro HasegawaDepartment of Hematology & Oncology, Kobe Children's Hospital, Minatojima-Minamimachi 1-6-7, Chuo-Ku, Kobe, 650-0047, Japan.
Yasuo NakagishiDepartment of General Pediatrics, Kobe Children's Hospital, Kobe, Japan.
Hiroshi KurosawaDivision of Pediatric Critical Care Medicine, Kobe Children's Hospital, Kobe, Japan.
Toshikatsu TanakaDepartment of Cardiology, Kobe Children's Hospital, Kobe, Japan.
Tadashi HatakeyamaDepartment of Pediatric Surgery, Kobe Children's Hospital, Kobe, Japan.
Yoshihiro OshimaDepartment of Cardiovascular Surgery, Kobe Children's Hospital, Kobe, Japan.
Yoshiyuki KosakaDepartment of Hematology & Oncology, Kobe Children's Hospital, Minatojima-Minamimachi 1-6-7, Chuo-Ku, Kobe, 650-0047, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to describe the etiology and clinical course in children with severe thrombocytosis (ST, platelet counts > 900 × 10

conclusionsWe found a low proportion of primary thrombocytosis and a low incidence of thrombosis in children with ST and ET. Our results suggest that pediatric ST and ET may share common characteristics and may have features that are distinct from those in adults. WHAT IS KNOWN: • Secondary thrombocytosis is a frequent finding in children. • Adult extreme thrombocytosis has been found to be associated with primary thrombocytosis. WHAT IS NEW: • There were no major differences in the baseline characteristics between children with severe and extreme thrombocytosis. • The incidence of thrombosis was markedly low in both severe and extreme thrombocytosis groups.

Indexed as

ThrombocytosisAdolescentChildChild, PreschoolFemaleHumansInfantInfant, NewbornLogistic ModelsMalePlatelet CountRetrospective StudiesRisk FactorsSeverity of Illness IndexThrombosisChildrenPlatelet countThrombocytosisThrombosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.